Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
NYSE COMPOSITE INDX
September 11, 2012 at 22:27 PM EDT
Investing in ‘junk DNA’
Now that scientists have revealed that the huge swaths of genetic code once dismissed as “junk DNA” are not so worthless, investors may wonder if there’s similar hidden value in the biotech sector. The short answer: maybe.
Read More >>
Alnylam Pharmaceuticals, Inc.
Isis Pharmaceuticals, Inc.
Myriad Genetics, Inc.
Roche Holding AG Basel American Depositary Shares
iShares Nasdaq Biotechnology Index Fund
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Terms and Conditions
Press Release Service
provided by PRConnect.
Stock quotes supplied by Six Financial
Bots go here